Houlihan Lokey, Inc.
NYSE:HLIFinancial - Capital Markets
-$1.78 today
- Market cap
- $9.66B
- Beta
- 0.95
- P/E (TTM)
- 22.0
- EPS (TTM)
- $6.42
- Dividend yield
- 1.77%
Volume 0.57M
Average 0.67M
HLI EBITDA Margin
EBITDA as a percentage of revenue.
Houlihan Lokey, Inc.NYSE: HLI
EBITDA Margin · Q2 FY2027 · quarter ended Sep 2026
EBITDA Margin narrows to 24.3%
EBITDA Margin was 24.3% in Q2 FY2027, down 2.9 pp from a year earlier. On a trailing-twelve-month basis it was 22.8%, down 2.8 pp year over year. Over 3 fiscal years it narrowed by 0.9 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 8 analysts of 26.1% for the fiscal year ending Mar 2027, up from 23.1% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 24.3%+7.4 pp QoQ
- Last fiscal yearMar 2026
- 23.1%-1.9 pp YoY
- LTMSep 2026
- 22.8%-2.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -2.9 pp | -0.6 pp | +2.3 pp |
| 1 year | -1.9 pp | +3.0 pp | +4.9 pp |
| 3 years | -0.9 pp | +3.0 pp | +3.9 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- 23.1%
- Year-over-year change
- -1.9pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 23.1% | -1.9pp |
| FY2025 | 2025-03-31 | 25.0% | +2.7pp |
| FY2024 | 2024-03-31 | 22.3% | -1.7pp |
| FY2023 | 2023-03-31 | 24.0% | -5.1pp |
| FY2022 | 2022-03-31 | 29.1% | — |
EBITDA Margin vs competitors
How HLI compares with its peers on the latest reported figures
- HLI's LTM Sep 2026 EBITDA Margin of 22.8% is the 7th highest of the 11 companies compared; the peer median is 23.2%.
- Its year-over-year change of -2.8 pp is the 9th highest of 11, against a peer median of +2.6 pp.
- Over three fiscal years its change of -0.9 pp compares with a peer median of -5.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 29.3% | +14.4 pp | -5.7 pp | |
| LTM Jun 2026 | 27.8% | +13.0 pp | -12.9 pp | |
| LTM Sep 2026 | 26.7% | +8.3 pp | -4.0 pp | |
| LTM Jun 2026 | 24.5% | +9.0 pp | +9.7 pp | |
| LTM Jun 2026 | 23.5% | +1.6 pp | -3.1 pp | |
| LTM Sep 2026 | 22.9% | -0.6 pp | -5.8 pp | |
| LTM Sep 2026 | 22.8% | -2.8 pp | -0.9 pp | |
| LTM Jun 2026 | 22.2% | +3.5 pp | -5.6 pp | |
| LTM Sep 2026 | 21.3% | +1.6 pp | -0.4 pp | |
| LTM Aug 2026 | 18.8% | -16.2 pp | -23.9 pp | |
| LTM Sep 2026 | 10.6% | -4.8 pp | -10.7 pp | |
| Peer median (excluding HLI) | 23.2% | +2.6 pp | -5.7 pp | |
Competitors are the stored peer set for HLI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 2.27B | 1.81B | 1.91B | 2.39B | 2.62B |
| Cost of Revenue | 1.41B | 1.11B | 1.18B | 1.47B | 42.63M |
| Gross Profit | 861.32M | 696.64M | 737.05M | 919.93M | 2.57B |
| Gross Margin | 37.9% | 38.5% | 38.5% | 38.5% | 98.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 127.81M | 142.9M | 185.32M | 188.48M | 0 |
| Operating Expenses | 248.46M | 354.9M | 374.19M | 418.38M | 1.96B |
| Depreciation & Amortization | 48.54M | 58.22M | 28.54M | 41.27M | 42.63M |
| EBITDA | 661.4M | 435.03M | 427.63M | 597.59M | 604.9M |
| EBITDA Margin | 29.1% | 24.0% | 22.3% | 25.0% | 23.1% |
| Operating Income | 612.86M | 341.74M | 362.86M | 501.54M | 618.54M |
| Operating Margin | 27.0% | 18.9% | 19.0% | 21.0% | 23.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (8.93M) | (17.74M) | 27.68M | 29.79M | (56.27M) |
| Income Before Tax | 603.94M | 324M | 390.54M | 531.34M | 562.27M |
| Pre-Tax Margin | 26.6% | 17.9% | 20.4% | 22.2% | 21.5% |
| Income Tax Expense | 165.61M | 69.78M | 110.24M | 131.62M | 138.09M |
| Net Income | 437.75M | 254.22M | 280.3M | 399.71M | 425.7M |
| Net Margin | 19.3% | 14.0% | 14.6% | 16.7% | 16.3% |
| EPS (Basic) | 6.74 | 4.01 | 4.36 | 6.08 | 6.40 |
| EPS (Diluted) | 6.41 | 3.76 | 4.11 | 5.82 | 6.22 |
| Weighted Avg Shares | 64.97M | 63.36M | 64.34M | 65.72M | 66.55M |
| Weighted Avg Shares (Diluted) | 68.26M | 67.59M | 68.16M | 68.66M | 68.43M |
Houlihan Lokey, Inc.
NYSE:HLI
Intrinsic Alpha fair value
Locked
Current Price
$139.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.